Cephalothin as a Carrier of 6-Mercaptopurine for Targeting Cancer Tissues

Cephalothin as a Carrier of 6-Mercaptopurine for Targeting Cancer Tissues

Show other versions (1)

A lower extracellular pH is one of the few well-documented physiological differences between tumour and normal tissues. On the other hand, elevated glutathione (GSH) level has been detected in many tumours compared with healthy surrounding tissues. The compound II: 3-(9H-purin-6-yl-thio) carbonothio...

Full description

Bibliographic Details
Main Authors:	Mohammad H. Mohammad, Haider J.Al-Karagully
Format:	Article
Language:	English
Published:	College of Pharmacy University of Baghdad 2017-03-01
Series:	Iraqi Journal of Pharmaceutical Sciences
Subjects:	Key words: 6-mercaptopurine, cancer, prodrug, targeting
Online Access:	https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/229

Similar Items

Cephalothin as a Carrier of 6-Mercaptopurine for Targeting Cancer Tissues
by: Mohammad H. Mohammad, et al.
Published: (2017-03-01)

Effects of 6– Mercaptopurine on Salivary Glands in Rabbit
by: Alhan D Al–Moula, et al.
Published: (2012-08-01)

Redox-Responsive Coordination Polymers of Dopamine-Modified Hyaluronic Acid with Copper and 6-Mercaptopurine for Targeted Drug Delivery and Improvement of Anticancer Activity against Cancer Cells
by: Bo Tao, et al.
Published: (2020-05-01)

Combination of Chlorambucil and Mercaptopurine Show Effective Anti-Cancer Effects in Mice Model
by: Xu W, et al.
Published: (2023-12-01)

Double Hydroxyl Salt as Smart Biocompatible pH-Responsive Carrier for 6-Mercaptopurine
by: Mariusz Sandomierski, et al.
Published: (2023-11-01)

Simultaneous Determination of 6-Mercaptopurine and its Oxidative Metabolites in Synthetic Solutions and Human Plasma using Spectrophotometric Multivariate Calibration Methods
by: Mohammad-Reza Rashidi, et al.
Published: (2011-06-01)

Mesoporous Silica Modified with Polydopamine and Zinc Ions as a Potential Carrier in the Controlled Release of Mercaptopurine
by: Mariusz Sandomierski, et al.
Published: (2023-06-01)

An improved HPLC method for the quantitation of 6-mercaptopurine and its metabolites in red blood cells
by: B.M. Oliveira, et al.
Published: (2004-05-01)

Impact of the homozygous mutation in Nudix hydrolase 15 on myelosuppression with 6-mercaptopurine in a European girl with acute lymphoblastic leukemia: a case report
by: Laura Elena Pineda-Lancheros, et al.
Published: (2023-11-01)

Tumor Microenvironment-Responsive 6-Mercaptopurine-Releasing Injectable Hydrogel for Colon Cancer Treatment
by: Sungjun Kim, et al.
Published: (2023-04-01)

Severe recurrent nocturnal hypoglycemia during chemotherapy with 6-mercaptopurine in a child with acute lymphoblastic leukemia
by: Eun Mi Cho, et al.
Published: (2018-12-01)

Inhibition of Xanthine Oxidase-Catalyzed Xanthine and 6-Mercaptopurine Oxidation by Flavonoid Aglycones and Some of Their Conjugates
by: Violetta Mohos, et al.
Published: (2020-05-01)

Early Initiation of Adalimumab Significantly Diminishes Postoperative Crohn’s Disease Endoscopic Recurrence and Is Superior to 6-Mercaptopurine Therapy: An Open-Label, Randomized Controlled Study
by: Ayal Hirsch, et al.
Published: (2023-12-01)

Quantification of 6-Mercaptopurine and Its Metabolites in Patients with Acute Lympoblastic Leukemia Using Dried Blood Spots and UPLC-MS/MS
by: Supandi Supandi, et al.
Published: (2018-04-01)

Use of Allopurinol to Mitigate 6-Mercaptopurine Associated Gastrointestinal Toxicity in Acute Lymphoblastic Leukemia
by: Shannon E. Conneely, et al.
Published: (2020-07-01)

Simultaneous Analysis of 6-Mercaptopurine, 6-Methylmercaptopurine, and 6-Thioguanosine-5’-monophosphate in Dried Blood Spot Using Ultra Performance Liquid Chromatography Tandem Mass Spectrometry
by: Supandi Supandi, et al.
Published: (2018-08-01)

Erythrocyte-incorporated 6-mercaptopurine metabolite levels are not affected by recent drug administration during maintenance therapy for childhood acute lymphoblastic leukemia
by: Lauryna Aukstikalne, et al.
Published: (2023-12-01)

Improved HPLC Quantification of 6-Mercaptopurine Metabolites in Red Blood Cells: Monitoring Data and Literature Analysis
by: Tiphaine Adam de Beaumais, et al.
Published: (2022-10-01)

Profound Hypoglycemia and High Anion Gap Metabolic Acidosis in a Pediatric Leukemic Patient Receiving 6-Mercaptopurine
by: Molly O’Shea, et al.
Published: (2024-01-01)

Preparation, Characterization, Pharmacokinetic, and Therapeutic Potential of Novel 6-Mercaptopurine-Loaded Oral Nanomedicines for Acute Lymphoblastic Leukemia
by: Zou Y, et al.
Published: (2021-02-01)

Mercaptopurine and inflammatory bowel disease: the other thiopurine
by: Fernando Bermejo, et al.

<i>TPMT*3C</i> as a Predictor of 6-Mercaptopurine-Induced Myelotoxicity in Thai Children with Acute Lymphoblastic Leukemia
by: Thawinee Jantararoungtong, et al.
Published: (2021-08-01)

A new insight of structures, bonding and electronic properties for 6-mercaptopurine and Ag8 clusters configurations: a theoretical perspective
by: Hongjiang Ren, et al.
Published: (2019-04-01)

Design and development of hydrogel nanoparticles for mercaptopurine
by: V Senthil, et al.
Published: (2010-01-01)

Preparation of 6-Mercaptopurine Loaded Liposomal Formulation for Enhanced Cytotoxic Response in Cancer Cells
by: Alam Jamal, et al.
Published: (2022-11-01)

Altered expression of DNMT3A gene in B-cell acute lymphoblastic leukemia by mercaptopurine
by: Seyedhossein Hekmatimoghaddam, et al.
Published: (2021-03-01)

Pharmacological and toxicological effects of 6-hydroxy-2-mercaptopurine and 6-thioguanine in in vitro and in vivo models of arthritis
by: Nordin, Nurul Syuhada
Published: (2021)

Preemptive <i>TPMT</i> Genotyping and Adherence to Genotype-Based Therapeutic Recommendations Reduces the Healthcare Cost in Patients Receiving Azathioprine or 6-Mercaptopurine for Autoimmune Diseases
by: Sarahí Valdez-Acosta, et al.
Published: (2023-07-01)

Clinical pharmacists’ knowledge, attitude, perception, and beliefs about the role of pharmacogenetic testing for genes polymorphisms when prescribing mercaptopurine
by: Norah O. Abanmy, et al.
Published: (2024-04-01)

Star Allele-Based Haplotyping versus Gene-Wise Variant Burden Scoring for Predicting 6-Mercaptopurine Intolerance in Pediatric Acute Lymphoblastic Leukemia Patients
by: Yoomi Park, et al.
Published: (2019-06-01)

Specific MRP4 Inhibitor Ceefourin-1 Enhances Apoptosis Induced by 6-Mercaptopurine in Jurkat Leukemic Cells, but Not in Normal Lymphoblast Cell Line CRL-1991
by: Edgardo Becerra, et al.
Published: (2022-05-01)

Cytostatic Drug 6-Mercaptopurine Degradation on Pilot Scale Reactors by Advanced Oxidation Processes: UV-C/H<sub>2</sub>O<sub>2</sub> and UV-C/TiO<sub>2</sub>/H<sub>2</sub>O<sub>2</sub> Kinetics
by: Luis A. González-Burciaga, et al.
Published: (2021-04-01)

Variants in TPMT, ITPA, ABCC4 and ABCB1 genes as predictors of 6-mercaptopurine induced toxicity in children with acute lymphoblastic leukemia
by: Milošević Goran, et al.
Published: (2018-01-01)

Azathioprine and 6-mercaptopurine-induced intrahepatic cholestasis of pregnancy: Case report and review of the literature
by: Maya Frank Wolf, et al.
Published: (2023-09-01)

The heterozygous NUDT15 variant is not associated with the severity of 6-mercaptopurine-related side effects in early intensification therapy for childhood acute lymphoblastic leukemia
by: Jimei Zhao, et al.
Published: (2023-01-01)

A randomised, double-blind, parallel-group trial to assess mercaptopurine versus placebo to prevent or delay recurrence of Crohn’s disease following surgical resection (TOPPIC)
by: Jack Satsangi, et al.
Published: (2017-09-01)

Gold nanoparticles loaded chitosan encapsulate 6-mercaptopurine as a novel nanocomposite for chemo-photothermal therapy on breast cancer
by: Amna H. Faid, et al.
Published: (2022-11-01)

Phagocytosis and Epithelial Cell Invasion by Crohn’s Disease-Associated Adherent-Invasive Escherichia coli Are Inhibited by the Anti-inflammatory Drug 6-Mercaptopurine
by: Federica Migliore, et al.
Published: (2018-05-01)

Effect of ITPA Polymorphism on Adverse Drug Reactions of 6-Mercaptopurine in Pediatric Patients with Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis
by: Yeonhong Lee, et al.
Published: (2022-03-01)

A Comprehensive Approach to Compatibility Testing Using Chromatographic, Thermal and Spectroscopic Techniques: Evaluation of Potential for a Monolayer Fixed-Dose Combination of 6-Mercaptopurine and Folic Acid
by: Edvin Brusač, et al.
Published: (2021-03-01)